FDA Approves CorMedix ' s Drug for Bloodstream Infections FDA Approves CorMedix ' s Drug for Bloodstream Infections

The FDA approved CorMedix ' s antimicrobial drug for reduction of catheter-related bloodstream infections in patients with kidney disease, allowing the company to launch its first commercial product.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Hematology-Oncology News Source Type: news